miR-1253 can also regulate FOXC2-AS1 in vascular smooth muscle cells (VSMCs) to decrease cellular proliferation and miR-1253 plasma levels were significantly reduced in patients with atherosclerosis [64]. Here, FOXC2 is linked to atherosclerosis.